Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00253695 · ClinicalTrials.gov registry record
Sleep, HIV Disease Progression, and Function in HIV Infected Children and Adolescents
A clinical trial, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- 90
- Enrollment target
NCT00253695: Completed study, sponsored by Baylor College of Medicine.
NCT00253695 is a clinical trial that has completed, run by Baylor College of Medicine. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00253695 has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
This study is a first step in approaching the gap existing between understanding sleep abnormalities, alterations in sleep-regulating cytokines and HIV-1 disease regulating cytokines, and abnormal higher cortical function.
Primary Outcome
Observational study only
Interventions
- DEVICE Wrist Actigraphy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2004-07 |
| Est. Completion | 2009-09 |
What the finished NCT00253695 record still lists
NCT00253695 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Wrist Actigraphy is the first listed.
NCT00253695 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00253695 about?
NCT00253695 is a clinical study titled "Sleep, HIV Disease Progression, and Function in HIV Infected Children and Adolescents". This study is a first step in approaching the gap existing between understanding sleep abnormalities, alterations in sleep-regulating cytokines and HIV-1 disease regulating cytokines, and abnormal higher cortical function.
What is the current status of trial NCT00253695?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2004-07. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00253695?
The interventions under investigation include: Wrist Actigraphy (DEVICE).
Who is sponsoring clinical trial NCT00253695?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia